ACell, Inc.

Equities

ACLL

US00444J1025

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2021	Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	CI
2020	ACell, Inc. Announces CE Mark Approval	CI

ACell, Inc. Appoints David Elliot as Vice President, Marketing

March 16, 2015

ACell, Inc. announced the selection of David Elliot as Vice President, Marketing. In this role, Elliot will lead all ACell marketing initiatives and offer strategic direction to advance ACell as a leading regenerative medicine company. Elliot previously served as Vice President, Academic Affairs and Marketing Services at St.

Jude Medical.

Latest news about ACell, Inc.

Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million.	20/21/20	CI
ACell, Inc. Announces CE Mark Approval	22/20/22	CI
Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. for $400 million.	16/20/16	CI
ACell, Inc. has withdrawn its IPO in the amount of $80 million.	20/20/20	CI
ACell, Inc. has filed an IPO in the amount of $86.25 million.	26/20/26	CI
ACell, Inc. Announces Launch of their New Product, Gentrix Hiatal at the 2019 Society of Laparoendoscopic Surgeons Minimally Invasive Surgery Week 2019 in New Orleans, Louisiana	05/19/05	CI
ACell, Inc. and Southmedic Announce Canadian Launch of Gentrix Surgical Matrix Family of Products	04/19/04	CI
ACell, Inc. Enters into Exclusive Long-Term Product Supply and Distribution Agreement with First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd	08/19/08	CI
ACell, Inc. and Southmedic Announce Canadian Launch of Cytal Wound Matrix and MicroMatrix	15/18/15	CI
ACell's Gentrix Surgical Matrix Provides Exceptional Long-Term Results in Complex Patient Populations for Durable Reinforcement of Ventral Hernias	08/18/08	CI
ACell to Host Grand Opening and Ribbon Cutting for Medical Learning Center	20/18/20	CI
ACell, Inc. Names Nino Pionati as Vice President, International and Business Development	08/18/08	CI
ACell, Inc. Announces Launch of Gentrix® Incisional	11/18/11	CI
ACell, Inc. Announces New Distribution Agreement with Applied Tissue Technologies LLC	21/18/21	CI
ACell, Inc. Announces Distribution Agreement with Southmedic, Incorporated	11/17/11	CI
ACell, Inc. Appoints Sally Maher to Board of Directors	31/16/31	CI
ACell, Inc. Names Brad Adams as Vice President of Sales	22/16/22	CI
ACell, Inc. Receives FDA Clearance for Concurrent Use of its Wound Management Devices	23/16/23	CI
ACell, Inc. Announces Management Changes	11/16/11	CI
ACell, Inc. Introduces Cytal Wound Matrix for Complex, Full-Thickness Wounds	08/16/08	CI
ACell, Inc. Announces Release of MatriStem Surgical Matrix Plus	28/15/28	CI
ACell, Inc. Appoints David Elliot as Vice President, Marketing	16/15/16	CI
ACell, Inc. Appoints Thomas Gilbert as a Chief Science Officer	05/15/05	CI
ACell, Inc. Announces Management Changes	16/14/16	CI
ACell, Inc. Announces First Patient in A U.S. Phase IV Clinical Trial	15/14/15	CI

Chart ACell, Inc.

Duration

Period

More charts

Company Profile

ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ACELL, INC.	-.--%	340M
ABBOTT LABORATORIES	-5.60%	181B
MEDTRONIC PLC	-4.45%	101B
BECTON, DICKINSON AND COMPANY	-4.15%	67.54B
DEXCOM, INC.	-8.63%	45.09B
CENCORA, INC.	+9.70%	44.37B
HOYA CORPORATION	+6.13%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+15.22%	29.85B
TERUMO CORPORATION	+14.80%	24.49B
WEST PHARMACEUTICAL SERVICES, INC.	-6.46%	23.99B

Other Medical Equipment, Supplies & Distribution